Risk Factors and Clinical Outcomes Associated With Sarcopenia in Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
26 Apr 2023
26 Apr 2023
Historique:
pubmed:
24
4
2023
medline:
24
4
2023
entrez:
24
04
2023
Statut:
aheadofprint
Résumé
Sarcopenia is underrecognized in patients with rheumatoid arthritis (RA). Risk factors of sarcopenia and its impact on outcomes in RA patients are relatively unknown. We conducted a systematic review to identify factors and outcomes associated with sarcopenia in RA. We conducted this review according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. We searched PubMed, Embase, CINAHL, and Web of Science databases by combining the following search concepts: (1) RA and (2) sarcopenia. Articles were included if they included RA patients, assessed for sarcopenia using a consensus working group definition, and assessed for clinical outcomes. Meta-analysis was performed using studies that shared the same sarcopenia definition and consistency in reporting patient or disease variables. Our search identified 3602 articles. After removal of duplicates, title and abstract screen, and full-text review, 16 articles were included for final analysis. All studies had observational study designs. The pooled prevalence of sarcopenia ranged from 24% to 30%, depending on the criteria for sarcopenia used. Factors associated with sarcopenia included higher 28-joint Disease Activity Scale scores (+0.39; 95% confidence interval, +0.02 to +0.77) and baseline methotrexate use (odds ratio, 0.70; 95% confidence interval, 0.51-0.97). Baseline glucocorticoid use had a positive correlation with sarcopenia in multiple studies. Several studies found lower bone mineral density and higher incidence of falls and fractures in patients with sarcopenia. Sarcopenia is prevalent in RA, and it may be associated with higher RA disease activity, lower bone mineral density, and increased falls and fractures. Therefore, early screening of sarcopenia in RA patients is important to incorporate into clinical rheumatology practice.
Identifiants
pubmed: 37092889
doi: 10.1097/RHU.0000000000001980
pii: 00124743-990000000-00109
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Tournadre A, Vial G, Capel F, et al. Sarcopenia. Joint Bone Spine . 2019;86:309–314. doi:10.1016/j.jbspin.2018.08.001.
doi: 10.1016/j.jbspin.2018.08.001
An HJ, Tizaoui K, Terrazzino S, et al. Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review. Int J Mol Sci . 2020;21:5678. doi:10.3390/ijms21165678.
doi: 10.3390/ijms21165678
Pan L, Xie W, Fu X, et al. Inflammation and sarcopenia: a focus on circulating inflammatory cytokines. Exp Gerontol . 2021;154:111544. doi:10.1016/j.exger.2021.111544.
doi: 10.1016/j.exger.2021.111544
Donini LM, Busetto L, Bauer JM, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr . 2020;39:2368–2388. doi:10.1016/j.clnu.2019.11.024.
doi: 10.1016/j.clnu.2019.11.024
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing . 2010;39:412–423. doi:10.1093/ageing/afq034.
doi: 10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing . 2019;48:601. doi:10.1093/ageing/afz046.
doi: 10.1093/ageing/afz046
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc . 2014;15:95–101. doi:10.1016/j.jamda.2013.11.025.
doi: 10.1016/j.jamda.2013.11.025
Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci . 2014;69:547–558. doi:10.1093/gerona/glu010.
doi: 10.1093/gerona/glu010
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc . 2011;12:249–256. doi:10.1016/j.jamda.2011.01.003.
doi: 10.1016/j.jamda.2011.01.003
Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle . 2022;13:86–99. doi:10.1002/jcsm.12783.
doi: 10.1002/jcsm.12783
Escriche-Escuder A, Fuentes-Abolafio IJ, Roldán-Jiménez C, et al. Effects of exercise on muscle mass, strength, and physical performance in older adults with sarcopenia: a systematic review and meta-analysis according to the EWGSOP criteria. Exp Gerontol . 2021;151:111420. doi:10.1016/j.exger.2021.111420.
doi: 10.1016/j.exger.2021.111420
Lovett M, Negm A, Ioannidis G, et al. Identifying patients with osteoarthritis at risk of sarcopenia using the SARC-F. Can Geriatr J . 2021;24:1–7. doi:10.5770/cgj.24.479.
doi: 10.5770/cgj.24.479
Manzano W, Lenchik L, Chaudhari AS, et al. Sarcopenia in rheumatic disorders: what the radiologist and rheumatologist should know. Skeletal Radiol . 2022;51:513–524. doi:10.1007/s00256-021-03863-z.
doi: 10.1007/s00256-021-03863-z
Gupta S, Dhillon RJS, Hasni S. Sarcopenia: a rheumatic disease? Rheum Dis Clin North Am . 2018;44:393–404. doi:10.1016/j.rdc.2018.03.001.
doi: 10.1016/j.rdc.2018.03.001
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet . 2019;393:2636–2646. doi:10.1016/S0140-6736(19)31138-9.
doi: 10.1016/S0140-6736(19)31138-9
Salaffi F, Farah S, Di Carlo M. Frailty syndrome in rheumatoid arthritis and symptomatic osteoarthritis: an emerging concept in rheumatology. Acta Biomed . 2020;91:274–296. doi:10.23750/abm.v91i2.9094.
doi: 10.23750/abm.v91i2.9094
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed) . 2021;74:790–799. doi:10.1016/j.rec.2021.07.010.
doi: 10.1016/j.rec.2021.07.010
Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol . 2014;14:135. doi:10.1186/1471-2288-14-135.
doi: 10.1186/1471-2288-14-135
Wells G, Shea B, O'Connel D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quailty of nonrandomised studies in meta-analyses. https://www.ohri.ca//programs/clinical_epidemiology/nosgen.pdf . Accessed September 22, 2022
Chen YF, Zong HX, Xu SQ, et al. Synergistic effect of sarcopenia and poor balance on osteoporotic vertebral fracture in Chinese patients with rheumatoid arthritis. Clin Rheumatol . 2021;40:3627–3637. doi:10.1007/s10067-021-05703-w.
doi: 10.1007/s10067-021-05703-w
Chu YR, Xu SQ, Wang JX, et al. Synergy of sarcopenia and vitamin D deficiency in vertebral osteoporotic fractures in rheumatoid arthritis. Clin Rheumatol . 2022;41:1979–1987. doi:10.1007/s10067-022-06125-y.
doi: 10.1007/s10067-022-06125-y
Tong JJ, Xu SQ, Wang JX, et al. Interactive effect of sarcopenia and falls on vertebral osteoporotic fracture in patients with rheumatoid arthritis. Arch Osteoporos . 2021;16:145. doi:10.1007/s11657-021-01017-1.
doi: 10.1007/s11657-021-01017-1
Lian L, Wang JX, Xu YC, et al. Sarcopenia may be a risk factor for osteoporosis in Chinese patients with rheumatoid arthritis. Int J Gen Med . 2022;15:2075–2085. doi:10.2147/IJGM.S349435.
doi: 10.2147/IJGM.S349435
Tada M, Yamada Y, Mandai K, et al. Osteosarcopenia synergistically increases the risk of falls in patients with rheumatoid arthritis. Osteoporos Sarcopenia . 2021;7:140–145. doi:10.1016/j.afos.2021.11.002.
doi: 10.1016/j.afos.2021.11.002
Tada M, Yamada Y, Mandai K, et al. Relationships of the stand-up time to falls and fractures in patients with rheumatoid arthritis: results from the CHIKARA study. Int J Rheum Dis . 2021;24:246–253. doi:10.1111/1756-185X.14033.
doi: 10.1111/1756-185X.14033
Wiegmann S, Armbrecht G, Borucki D, et al. Association between sarcopenia, physical performance and falls in patients with rheumatoid arthritis: a 1-year prospective study. BMC Musculoskelet Disord . 2021;22:885. doi:10.1186/s12891-021-04605-x.
doi: 10.1186/s12891-021-04605-x
Ekici R, Erden A, Güven SC, et al. Prevalence of sarcopenia and clinical implications in patients with newly diagnosed rheumatoid arthritis. Nutrition . 2021;90:111353. doi:10.1016/j.nut.2021.111353.
doi: 10.1016/j.nut.2021.111353
Ma JD, Chen CT, Lin JZ, et al. Muscle wasting, a neglected complication associated with physical dysfunction in elderly patients with rheumatoid arthritis: a cross-sectional observational study. Scand J Rheumatol . 2021;50:280–289. doi:10.1080/03009742.2020.1842902.
doi: 10.1080/03009742.2020.1842902
Mochizuki T, Yano K, Ikari K, et al. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: a cross-sectional study. Geriatr Gerontol Int . 2019;19:907–912. doi:10.1111/ggi.13747.
doi: 10.1111/ggi.13747
Mochizuki T, Yano K, Ikari K, et al. Sarcopenia in Japanese younger patients with rheumatoid arthritis: a cross-sectional study. Mod Rheumatol . 2021;31:504–505. doi:10.1080/14397595.2020.1740411.
doi: 10.1080/14397595.2020.1740411
Torii M, Hashimoto M, Hanai A, et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod Rheumatol . 2019;29:589–595. doi:10.1080/14397595.2018.1510565.
doi: 10.1080/14397595.2018.1510565
Vlietstra L, Stebbings S, Meredith-Jones K, et al. Sarcopenia in osteoarthritis and rheumatoid arthritis: the association with self-reported fatigue, physical function and obesity. PloS One . 2019;14:e0217462. doi:10.1371/journal.pone.0217462.
doi: 10.1371/journal.pone.0217462
Yun HW, Kim CJ, Kim JW, et al. The assessment of muscle mass and function in patients with long-standing rheumatoid arthritis. J Clin Med . 2021;10:3458. doi:10.3390/jcm10163458.
doi: 10.3390/jcm10163458
Brance ML, Di Gregorio S, Pons-Estel BA, et al. Prevalence of sarcopenia and whole-body composition in rheumatoid arthritis. J Clin Rheumatol . 2021;27(6S):S153–S160. doi:10.1097/RHU.0000000000001549.
doi: 10.1097/RHU.0000000000001549
Zhang L, Mao D, Zhang Q. Correlation between sarcopenia and nailfold microcirculation, serum 25-hydroxycholecalciferol (vitamin D 3 ) and IL-17 levels in female patients with rheumatoid arthritis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub . 2021;165:264–269. doi:10.5507/bp.2020.036.
doi: 10.5507/bp.2020.036
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing . 2014;43:748–759. doi:10.1093/ageing/afu115.
doi: 10.1093/ageing/afu115
Nascimento CM, Ingles M, Salvador-Pascual A, et al. Sarcopenia, frailty and their prevention by exercise. Free Radic Biol Med . 2019;132:42–49. doi:10.1016/j.freeradbiomed.2018.08.035.
doi: 10.1016/j.freeradbiomed.2018.08.035
Maska L, Anderson J, Michaud K. Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), improved Health Assessment Questionnaire (improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken) . 2011;63(Suppl 11):S4–S13. doi:10.1002/acr.20620.
doi: 10.1002/acr.20620
Shang Y, Kuang M, Wang Z, et al. An ultrashort peptide-based supramolecular hydrogel mimicking IGF-1 to alleviate glucocorticoid-induced sarcopenia. ACS Appl Mater Interfaces . 2020;12:34678–34688. doi:10.1021/acsami.0c09973.
doi: 10.1021/acsami.0c09973
Li YZ, Zhuang HF, Cai SQ, et al. Low grip strength is a strong risk factor of osteoporosis in postmenopausal women. Orthop Surg . 2018;10:17–22. doi:10.1111/os.12360.
doi: 10.1111/os.12360
Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) task force. J Nutr Health Aging . 2009;13:881–889. doi:10.1007/s12603-009-0246-z.
doi: 10.1007/s12603-009-0246-z
Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc . 2020;68:1410–1418. doi:10.1111/jgs.16372.
doi: 10.1111/jgs.16372
Higgins SC, Adams J, Hughes R. Measuring hand grip strength in rheumatoid arthritis. Rheumatol Int . 2018;38:707–714. doi:10.1007/s00296-018-4024-2.
doi: 10.1007/s00296-018-4024-2
Kojima T, Ishikawa H, Tanaka S, et al. Validation and reliability of the timed up and go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional study. Int J Rheum Dis . 2018;21:1793–1800. doi:10.1111/1756-185X.13237.
doi: 10.1111/1756-185X.13237
Li G, Chen M, Li X, et al. Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative. Bone . 2019;127:129–134. doi:10.1016/j.bone.2019.06.006.
doi: 10.1016/j.bone.2019.06.006
Teeratakulpisarn N, Charoensri S, Theerakulpisut D, et al. FRAX score with and without bone mineral density: a comparison and factors affecting the discordance in osteoporosis treatment in Thais. Arch Osteoporos . 2021;16:44. doi:10.1007/s11657-021-00911-y.
doi: 10.1007/s11657-021-00911-y
Naves M, Díaz-López JB, Gómez C, et al. The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population. Osteoporos Int . 2003;14:520–524. doi:10.1007/s00198-003-1405-4.
doi: 10.1007/s00198-003-1405-4